Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma.

@article{Maraldo2013EstimatedRO,
  title={Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma.},
  author={Maja Vestm\o Maraldo and Nils Patrik Brodin and Marianne Aznar and Ivan Richter Vogelius and Per Munck af Rosensch{\"o}ld and Peter Meidahl Petersen and Lena Specht},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2013},
  volume={24 8},
  pages={2113-8}
}
BACKGROUND Hodgkin lymphoma (HL) survivors have an increased morbidity and mortality from secondary cancers and cardiovascular disease (CD). We evaluate doses with involved node radiotherapy (INRT) delivered as 3D conformal radiotherapy (3D CRT), volumetric modulated arc therapy (VMAT), or proton therapy (PT), compared with the extensive Mantle Field (MF). PATIENTS AND METHODS For 27 patients with early-stage, mediastinal HL, treated with chemotherapy and INRT delivered as 3D CRT (30 Gy), we… CONTINUE READING
37 Citations
25 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 37 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 25 references

Vogelius IR et al Involved node radiation therapy: an effective Alternative in Early-Stage Hodgkin Lymphoma

  • MV Maraldo, MC Aznar
  • Int J Radiat Oncol Biol Phys
  • 2013
2 Excerpts

Similar Papers

Loading similar papers…